Skip to main content

Atopic Hand Eczema

  • Chapter
  • First Online:
Textbook of Hand Eczema

Abstract

Atopic dermatitis (AD) is an allergic, inflammatory skin disorder, characterized by itching and relapsing dermatitis. The lesional skin is occupied by increased numbers of T cells, eosinophils, and mast cells, and while the acute phase of the inflammatory response in the skin is dominated by Th2 cells, in the chronic phase Th1 cells start to take over. Genetic factors play an important role in the onset of atopic dermatitis, and polymorphism in the genes controlling either skin barrier function or adaptive and innate immune responses has been shown to associate with AD in several studies. However, the rapid increase of this disease indicates that environmental factors also play a crucial role. Evidence suggests that reduced microbial exposure due to urbanization, improved hygiene, and efficient health-care measures may account for increased rates of allergic diseases such as AD. The diagnosis of atopic hand dermatitis assumes the fact that the patient has atopic dermatitis, where the major criteria for diagnosis are pruritus and, additionally, typical clinical features. Treatment of atopic hand dermatitis contains avoidance of irritants and possible allergens and use of emollients, topical corticosteroids, and topical calcineurin inhibitors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bieber T. Atopic dermatitis. Ann Dermatol. 2011;22:125–37.

    Article  Google Scholar 

  2. Novak N, Leung DY. Advances in atopic dermatitis. Curr Opin Immunol. 2011;23:778–83.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011;242:233–46.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Barnes KC. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol. 2010;125:16–29. e1-11; quiz 30–1.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38:441–6.

    Article  CAS  PubMed  Google Scholar 

  6. Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol. 2010;105:99–106. quiz 7–9, 17.

    Article  CAS  PubMed  Google Scholar 

  7. Kezic S, O’Regan GM, Yau N, Sandilands A, Chen H, Campbell LE, et al. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy. 2011;66:934–40.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. O’Regan GM, Kemperman PM, Sandilands A, Chen H, Campbell LE, Kroboth K, et al. Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes. J Allergy Clin Immunol. 2010;126:574–80.e1.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Henderson J, Northstone K, Lee SP, Liao H, Zhao Y, Pembrey M, et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol. 2008;121:872–7.e9.

    Article  CAS  PubMed  Google Scholar 

  10. Marenholz I, Nickel R, Ruschendorf F, Schulz F, Esparza-Gordillo J, Kerscher T, et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol. 2006;118:866–71.

    Article  CAS  PubMed  Google Scholar 

  11. De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011;127:773–86.e1-7.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Esparza-Gordillo J, Weidinger S, Folster-Holst R, Bauerfeind A, Ruschendorf F, Patone G, et al. A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet. 2009;41:596–601.

    Article  CAS  PubMed  Google Scholar 

  13. Henry J, Hsu CY, Haftek M, Nachat R, de Koning HD, Gardinal-Galera I, et al. Hornerin is a component of the epidermal cornified cell envelopes. FASEB J. 2011;25:1567–76.

    Article  CAS  PubMed  Google Scholar 

  14. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007;120:150–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Kim BE, Leung DY, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol. 2008;126:332–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Wills-Karp M. Allergen-specific pattern recognition receptor pathways. Curr Opin Immunol. 2010;22:777–82.

    Article  CAS  PubMed  Google Scholar 

  17. Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, Klotz M, Werfel T, Herz U, et al. The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol. 2004;113:565–7.

    Article  CAS  PubMed  Google Scholar 

  18. Novak N, Yu CF, Bussmann C, Maintz L, Peng WM, Hart J, et al. Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy. 2007;62:766–72.

    Article  CAS  PubMed  Google Scholar 

  19. Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol. 2003;171:3262–9.

    CAS  PubMed  Google Scholar 

  20. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151–60.

    Article  CAS  PubMed  Google Scholar 

  21. Howell MD, Boguniewicz M, Pastore S, Novak N, Bieber T, Girolomoni G, et al. Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol. 2006;121:332–8.

    Article  CAS  PubMed  Google Scholar 

  22. Lebre MC, van Capel TM, Bos JD, Knol EF, Kapsenberg ML, de Jong EC. Aberrant function of peripheral blood myeloid and plasmacytoid dendritic cells in atopic dermatitis patients. J Allergy Clin Immunol. 2008;122:969–76.e5.

    Article  CAS  PubMed  Google Scholar 

  23. Novak N, Allam JP, Hagemann T, Jenneck C, Laffer S, Valenta R, et al. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J Allergy Clin Immunol. 2004;114:364–70.

    Article  CAS  PubMed  Google Scholar 

  24. Wollenberg A, Wagner M, Gunther S, Towarowski A, Tuma E, Moderer M, et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol. 2002;119:1096–102.

    Article  CAS  PubMed  Google Scholar 

  25. Boguniewicz M, Leung DY. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol. 2010;125:4–13. quiz 4–5.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Werfel T. The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol. 2009;129:1878–91.

    Article  CAS  PubMed  Google Scholar 

  27. Hauk PJ. The role of food allergy in atopic dermatitis. Curr Allergy Asthma Rep. 2008;8:188–94.

    Article  CAS  PubMed  Google Scholar 

  28. Hostetler SG, Kaffenberger B, Hostetler T, Zirwas MJ. The role of airborne proteins in atopic dermatitis. J Clin Aesthet Dermatol. 2010;3:22–31.

    PubMed Central  PubMed  Google Scholar 

  29. Cardona ID, Goleva E, Ou LS, Leung DY. Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. J Allergy Clin Immunol. 2006;117:688–95.

    Article  CAS  PubMed  Google Scholar 

  30. Laouini D, Kawamoto S, Yalcindag A, Bryce P, Mizoguchi E, Oettgen H, et al. Epicutaneous sensitization with superantigen induces allergic skin inflammation. J Allergy Clin Immunol. 2003;112:981–7.

    Article  CAS  PubMed  Google Scholar 

  31. Leung DY, Harbeck R, Bina P, Reiser RF, Yang E, Norris DA, et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest. 1993;92:1374–80.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Lin YT, Wang CT, Chao PS, Lee JH, Wang LC, Yu HH, et al. Skin-homing CD4+ Foxp3+ T cells exert Th2-like function after staphylococcal superantigen stimulation in atopic dermatitis patients. Clin Exp Allergy. 2011;41:516–25.

    Article  CAS  PubMed  Google Scholar 

  33. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med. 1992;175:91–8.

    Article  CAS  PubMed  Google Scholar 

  34. Hong SC, Waterbury G, Janeway Jr CA. Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptor. J Exp Med. 1996;183:1437–46.

    Article  CAS  PubMed  Google Scholar 

  35. Misery L. Atopic dermatitis and the nervous system. Clin Rev Allergy Immunol. 2011;41(3):259–66.

    Article  CAS  PubMed  Google Scholar 

  36. Schaub B, Liu J, Hoppler S, Schleich I, Huehn J, Olek S, et al. Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells. J Allergy Clin Immunol. 2009;123:774–82.e5.

    Article  CAS  PubMed  Google Scholar 

  37. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol. 2001;1:69–75.

    Article  CAS  PubMed  Google Scholar 

  38. Williams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ, et al. The U.K. working party’s diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol. 1994;131:406–16.

    Article  CAS  PubMed  Google Scholar 

  39. Lodén M, Andersson AC, Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol. 1999;140(2):264–7.

    Article  PubMed  Google Scholar 

  40. Van Der Meer JB, Glazenburg EJ, Mulder PG, Eggink HF, Coenraads PJ. The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic Dermatitis Study Group. Br J Dermatol. 1999;140(6):1114–21.

    Google Scholar 

  41. Reitamo S, Ortonne JP, Sand C, Cambazard F, Bieber T, Fölster-Holst R, et al. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol. 2005;152(6):1282–9.

    Article  CAS  PubMed  Google Scholar 

  42. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess. 2000;4(37):1–191.

    CAS  PubMed  Google Scholar 

  43. Granlund H, Erkko P, Remitz A, Langeland T, Helsing P, Nuutinen M, et al. Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis. Acta Derm Venereol. 2001;81(1):22–7.

    Article  CAS  PubMed  Google Scholar 

  44. Meggitt SJ, Gray JC, Reynolds NJ. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet. 2006;367(9513):839–46.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antti Lauerma M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lehtimäki, S., Lauerma, A. (2014). Atopic Hand Eczema. In: Alikhan, A., Lachapelle, JM., Maibach, H. (eds) Textbook of Hand Eczema. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39546-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-39546-8_12

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-39545-1

  • Online ISBN: 978-3-642-39546-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics